Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1951 1
1955 2
1956 1
1957 1
1958 2
1959 2
1961 1
1962 2
1963 9
1964 17
1965 8
1966 12
1967 19
1968 18
1969 27
1970 29
1971 42
1972 33
1973 39
1974 31
1975 30
1976 32
1977 35
1978 40
1979 46
1980 47
1981 54
1982 28
1983 32
1984 30
1985 35
1986 24
1987 26
1988 30
1989 40
1990 29
1991 36
1992 32
1993 37
1994 24
1995 21
1996 23
1997 24
1998 17
1999 20
2000 11
2001 17
2002 13
2003 14
2004 20
2005 2
2006 6
2007 13
2008 7
2009 19
2010 15
2011 8
2012 14
2013 19
2014 14
2015 18
2016 14
2017 6
2018 10
2019 9
2020 15
2021 11
2022 16
2023 5
2024 10
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,352 results

Results by year

Filters applied: . Clear all
Page 1
Systemic side effects of glaucoma medications.
Arbabi A, Bao X, Shalaby WS, Razeghinejad R. Arbabi A, et al. Clin Exp Optom. 2022 Mar;105(2):157-165. doi: 10.1080/08164622.2021.1964331. Epub 2021 Aug 17. Clin Exp Optom. 2022. PMID: 34402741 Free article. Review.
Intraocular pressure-lowering options include topical and systemic medications, lasers, and surgical procedures. ...This review will discuss the systemic adverse effects of carbonic anhydrase inhibitors, sympathomimetics, para-sympathomimetics, beta blockers, …
Intraocular pressure-lowering options include topical and systemic medications, lasers, and surgical procedures. ...This review will …
Pharmacotherapy of intraocular pressure: part I. Parasympathomimetic, sympathomimetic and sympatholytics.
Costagliola C, dell'Omo R, Romano MR, Rinaldi M, Zeppa L, Parmeggiani F. Costagliola C, et al. Expert Opin Pharmacother. 2009 Nov;10(16):2663-77. doi: 10.1517/14656560903300103. Expert Opin Pharmacother. 2009. PMID: 19874249 Review.
Elevated intraocular pressure (IOP) has been recognized as the major risk factor for the development of glaucoma and a wide range of options are now available to reduce it: medical treatment, laser, filtering, or cyclodestructive surgery (alone or in combination). ...This …
Elevated intraocular pressure (IOP) has been recognized as the major risk factor for the development of glaucoma and a wide range of …
Epinephrine.
Dalal R, Grujic D. Dalal R, et al. 2024 Nov 23. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Nov 23. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 29489283 Free Books & Documents.
Epinephrine is approved by the US Food and Drug Administration (FDA) for treating type 1 hypersensitivity reactions (including anaphylaxis), managing hypotension from septic shock, and inducing mydriasis during intraocular surgeries. Epinephrine exerts its effects through …
Epinephrine is approved by the US Food and Drug Administration (FDA) for treating type 1 hypersensitivity reactions (including anaphylaxis), …
[Drug-induced glaucoma].
Ostroumova OD, Shikh EV, Rebrova EV, Ryazanova AY, Moshetova LK. Ostroumova OD, et al. Vestn Oftalmol. 2020;136(2):107-116. doi: 10.17116/oftalma2020136021107. Vestn Oftalmol. 2020. PMID: 32366078 Russian.
Glaucoma is seen as a heterogeneous group of diseases characterized by optical neuropathy with associated visual field loss; one of the main risk factors for its development is increased intraocular pressure (IOP). In the case of drug-induced glaucoma (DIG), patients devel …
Glaucoma is seen as a heterogeneous group of diseases characterized by optical neuropathy with associated visual field loss; one of the main …
Non-steroidal drug-induced glaucoma.
Razeghinejad MR, Pro MJ, Katz LJ. Razeghinejad MR, et al. Eye (Lond). 2011 Aug;25(8):971-80. doi: 10.1038/eye.2011.128. Epub 2011 Jun 3. Eye (Lond). 2011. PMID: 21637303 Free PMC article. Review.
Indeed, many routinely used drugs that have sympathomimetic or parasympatholytic properties can cause pupillary block CAG in individuals with narrow iridocorneal angle. ...
Indeed, many routinely used drugs that have sympathomimetic or parasympatholytic properties can cause pupillary block CAG in individu …
Betaxolol: A comprehensive profile.
Al-Wadei MJ, Bakheit AH, Abdel-Aziz AA, Wani TA. Al-Wadei MJ, et al. Profiles Drug Subst Excip Relat Methodol. 2021;46:91-136. doi: 10.1016/bs.podrm.2020.07.002. Epub 2020 Aug 21. Profiles Drug Subst Excip Relat Methodol. 2021. PMID: 33461701 Review.
Betaxolol is a relatively cardioselective beta-adrenoceptor blocking drug, with no partial agonist (intrinsic sympathomimetic) activity and weak membrane-stabilizing (local anesthetic) activity. Betaxolol selectively and competitively binds to and blocks beta-1 (beta1) adr …
Betaxolol is a relatively cardioselective beta-adrenoceptor blocking drug, with no partial agonist (intrinsic sympathomimetic) activi …
Glaucoma.
Armaly MF. Armaly MF. Arch Ophthalmol. 1973 Dec;90(6):485-501. doi: 10.1001/archopht.1973.01000050485018. Arch Ophthalmol. 1973. PMID: 4586266 Review. No abstract available.
Hypersecretion glaucoma.
Kalra BR, Sood NN, Agarwal HC. Kalra BR, et al. Indian J Ophthalmol. 1984 Mar-Apr;32(2):109-11. Indian J Ophthalmol. 1984. PMID: 6526461 Free article. No abstract available.
Ocular Pharmacology.
Rehovsky J. Rehovsky J. Insight. 2016 Spring;41(2):17-21. Insight. 2016. PMID: 27209686
Medications are a common treatment for glaucoma. Pharmacologic agents include sympathomimetics, beta-blockers, miotics (direct acting and cholinesterase inhibitors), carbonic anhydrase inhibitors, and prostaglandin agonists. ...
Medications are a common treatment for glaucoma. Pharmacologic agents include sympathomimetics, beta-blockers, miotics (direct acting …
1,352 results